(NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) in adults and adolescents with moderate-to-severe atopic ...

The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment ...

During Parliament's plenary session on Wednesday afternoon, the Minister for Agriculture, Fisheries, Food and Animal Rights - Anton Refalo - announced that the Newcastle Disease that was found in some ...

Last week Frank Esposito shared his forecast for summer resin prices for PE, PP, PS and PVC as tumultuous conditions are keeping prices flat or down. Watch a clip of it in Material Insights. From the ...

EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN: Stamford, Connecticut Tuesday, May 27, 2025, 12:00 Hr ...

SpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending conditional ...

Mirdametinib is approved in the U.S. for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) ...

Evidence of Disease Modification on Clinical and Biomarker Measures: Favorable trends indicating stability or improvement were observed in patients with ATTRv-PN, including six patients previously ...

Loretta Swit, a star of TV's "M*A*S*H," dies at 87 ‘I’m polyamorous – this is how we manage our money’ JPMorgan’s Jamie Dimon Predicts ‘Crack in the Bond Market,’ Citing U.S. Fiscal Mess Scientists ...

Share on Pinterest Michelle (pictured left) and her daughter Samantha Pearson live with NF1-PN, a chronic disease in which tumors grow along nerves. Photography courtesy of Michelle Pearson A ...

The late onset of ATTR-PN and mild initial symptoms do not interfere with fertility and could contribute to the disease’s spread, they added. “We found a significant founder effect by combining the ...